How to buy Boston Scientific shares | $33.6

Own Boston Scientific shares in just a few minutes. Share price changes are updated daily.

Fact checked

Boston Scientific Corporation (BSX) is a leading medical devices business based in the US. It opened the day at $33.76 after a previous close of $34. During the day the price has varied from a low of $33.4327 to a high of $34.14. The latest price was $33.6 (25 minute delay). Boston Scientific is listed on the NYSE and employs 36,000 staff. All prices are listed in US Dollars.

How to buy shares in Boston Scientific

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: BSX in this case.
  5. Research Boston Scientific shares. The platform should provide the latest information available.
  6. Buy your Boston Scientific shares. It's that simple.
The whole process can take as little as 15 minutes.

How has Coronavirus impacted Boston Scientific's share price?

Since the stock market crash in March caused by coronavirus, Boston Scientific's share price has had significant negative movement.

Its last market close was $37.77, which is 11.38% down on its pre-crash value of $42.62 and 56.72% up on the lowest point reached during the March crash when the shares fell as low as $24.1.

If you had bought $1,000 worth of Boston Scientific shares at the start of February 2020, those shares would have been worth $611.65 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $894.39.

Boston Scientific share price

Use our graph to track the performance of BSX stocks over time.

Boston Scientific shares at a glance

Information last updated 2020-12-11.
Open$33.76
High$34.14
Low$33.4327
Close$33.6
Previous close$34
Change $-0.4
Change % -1.176%
Volume 11,848,423
Information last updated 2020-12-27.
52-week range$24.1 - $46.13
50-day moving average $34.8553
200-day moving average $37.1631
Wall St. target price$43.33
PE ratio 13.2783
Dividend yield N/A (0%)
Earnings per share (TTM) $2.605
Promoted
eToro Free Stocks

Invest in Boston Scientific shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Your first 100 trades are free with Fineco, T&Cs apply.
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Stake
£0
£0
Zero platform fee
Join and receive a free share worth up to £100
Access unlimited commission-free trading on 3,800+ US stocks and ETFs with Stake. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Degiro Share Dealing
£1.75 + 0.022% (max £5.00)
£1.75 + 0.022% (max £5.00)
Portfolio transfer fees (in & out)
Degiro is widely seen as one of the best low-cost share brokers, for people who are looking to trade regularly. Capital at risk.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Open an ISA, Trading Account or SIPP you will get £100 of free trades to buy or sell any investment (new customers only).
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Moneyfarm helps you meet your investment goals with fully-managed portfolios designed around you. Capital at risk.
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
0.61%
N/A
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
Penfold
Penfold
No minimum
4 portfolios
0.75-0.88%
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Boston Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Boston Scientific price performance over time

Historical closes compared with the last close of $33.6

1 week (2021-01-15) -7.51%
1 month (2020-12-22) -2.21%
3 months (2020-10-22) -8.84%
6 months (2020-07-22) -12.48%
1 year (2020-01-22) -23.72%
2 years (2019-01-22) -9.82%
3 years (2018-01-22) 21.26%
5 years (2016-01-22) 88.24%

Is Boston Scientific under- or over-valued?

Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Boston Scientific's P/E ratio

Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Boston Scientific shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Boston Scientific's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

Boston Scientific's PEG ratio

Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.7016. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Boston Scientific's PEG ratio in relation to those of similar companies.

Boston Scientific's EBITDA

Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $2.1 billion (£1.6 billion).

The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.

To put Boston Scientific's EBITDA into context you can compare it against that of similar companies.

Boston Scientific financials

Revenue TTM $10.1 billion
Operating margin TTM 9.85%
Gross profit TTM $7.6 billion
Return on assets TTM 2.16%
Return on equity TTM 29.32%
Profit margin 36.64%
Book value $10.87
Market capitalisation $49 billion

TTM: trailing 12 months

How to short and sell Boston Scientific shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "BSX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 16.3 million Boston Scientific shares held short by investors – that's known as Boston Scientific's "short interest". This figure is 26.1% up from 13.0 million last month.

There are a few different ways that this level of interest in shorting Boston Scientific shares can be evaluated.

Boston Scientific's "short interest ratio" (SIR)

Boston Scientific's "short interest ratio" (SIR) is the quantity of Boston Scientific shares currently shorted divided by the average quantity of Boston Scientific shares traded daily (recently around 16.7 million). Boston Scientific's SIR currently stands at 0.98. In other words for every 100,000 Boston Scientific shares traded daily on the market, roughly 980 shares are currently held short.

To gain some more context, you can compare Boston Scientific's short interest ratio against those of similar companies.

However Boston Scientific's short interest can also be evaluated against the total number of Boston Scientific shares, or, against the total number of tradable Boston Scientific shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Boston Scientific's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Boston Scientific shares in existence, roughly 10 shares are currently held short) or 0.0116% of the tradable shares (for every 100,000 tradable Boston Scientific shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Boston Scientific.

Find out more about how you can short Boston Scientific stock.

Boston Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Boston Scientific's total ESG risk score

Total ESG risk: 29.23

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

To gain some more context, you can compare Boston Scientific's total ESG risk score against those of similar companies.

Boston Scientific's environmental score

Environmental score: 1.51/100

Boston Scientific's social score

Social score: 12.87/100

Boston Scientific's governance score

Governance score: 7.87/100

Boston Scientific's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.

Wondering how that compares? Below are the controversy scores of similar companies.

Environmental, social, and governance (ESG) summary

Boston Scientific Corporation was last rated for ESG on: 2019-01-01.

Total ESG score 29.23
Total ESG percentile 56.94
Environmental score 1.51
Social score 12.87
Governance score 7.87
Level of controversy 3

Boston Scientific share dividends

We're not expecting Boston Scientific to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

You may also wish to consider:

Have Boston Scientific's shares ever split?

Boston Scientific's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.

Boston Scientific share price volatility

Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $24.1 up to $46.13. A popular way to gauge a stock's volatility is its "beta".

BSX.US volatility(beta: 0.86)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8567. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).

To put Boston Scientific's beta into context you can compare it against those of similar companies.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Boston Scientific overview

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions

More guides on Finder

  • How to buy Boston Scientific shares

    Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Charlie’s Holdings shares

    Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Lemonade shares | $50.05

    Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Unity Software shares | $111.51

    Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor

  • How to buy FuelCell Energy shares | $3.745

    Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Boston Scientific shares | $0.1275

    Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor

  • How to buy Zomedica Pharmaceuticals shares | $0.93

    Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.

  • How to buy YRC Worldwide shares | $4.66

    Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.

  • How to buy Xeros Technology Group shares | 220p

    Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.

  • How to buy Xpediator shares | 33.5p

    Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site